[artículo] 
inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 358-364

Título :	Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study
Tipo de documento:	texto impreso
Autores:	Kirsten Behnke, Autor ; Jesper Søgaard, Autor ; Stephen Martin, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 358-364
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antidepresivos Tricíclicos, Trastorno depresivo, Mianserin, Mirtazapina, Sertralina, Disfunción sexual fisiológica
Resumen:	This multinational, randomized, double-blind study was specifically designed to prospectively compare the onset of antidepressant efficacy of mirtazapine orally disintegrating tablets and sertraline at dosages commonly used in clinical practice. A total of 345 patients with major depressive episode (DSM-IV) received mirtazapine (30–45 mg/d) or sertraline (50–150 mg/d) for 8 weeks.
Link:	./index.php?lvl=notice_display&id=31010

[artículo] Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study [texto impreso] / Kirsten Behnke, Autor ; Jesper Søgaard, Autor ; Stephen Martin, Autor . - 2023 . - pp. 358-364.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 358-364

Palabras clave:	Antidepresivos Tricíclicos, Trastorno depresivo, Mianserin, Mirtazapina, Sertralina, Disfunción sexual fisiológica
Resumen:	This multinational, randomized, double-blind study was specifically designed to prospectively compare the onset of antidepressant efficacy of mirtazapine orally disintegrating tablets and sertraline at dosages commonly used in clinical practice. A total of 345 patients with major depressive episode (DSM-IV) received mirtazapine (30–45 mg/d) or sertraline (50–150 mg/d) for 8 weeks.
Link:	./index.php?lvl=notice_display&id=31010